Showing results (821-830 of 1,044) with videos related to

Sort By:
Pageof 105
Frontiers in Oncology|March 9, 2023
Flavin fluorescence lifetime and autofluorescence optical redox ratio for improved visualization and classification of brain tumorsDavid Reichert, Lisa I Wadiura, Mikael T Erkkilae, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumabElisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, et al.
Microbial Genomics|June 27, 2020
Comparative genomics of the genus <i>Roseburia</i> reveals divergent biosynthetic pathways that may influence colonic competition among speciesEthan T Hillman, Ariangela J Kozik, Casey A Hooker, et al.
Journal of Neuro-Oncology|August 6, 2023
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysisAlexandra Lang, Raphael L Jeron, Bastian Lontzek, et al.
Leukemia & Lymphoma|October 17, 2019
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignanciesTanya Siddiqi, Paul Frankel, Jan H Beumer, et al.
Neuro-Oncology|October 31, 2014
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastomaAnna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, et al.
Neuroimage. Clinical|September 25, 2020
High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSIGilbert Hangel, Cornelius Cadrien, Philipp Lazen, et al.
Nature Genetics|March 30, 2011
The value of dataBarend Mons, Herman van Haagen, Christine Chichester, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignanciesAntoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Cancer Science|June 24, 2020
HS2ST1-dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behaviorArchana Vijaya Kumar, Stéphane Brézillon, Valérie Untereiner, et al.
Pageof 105